Journal
ABDOMINAL IMAGING
Volume 37, Issue 6, Pages 1021-1031Publisher
SPRINGER
DOI: 10.1007/s00261-012-9855-9
Keywords
Colonic carcinoma; Rectal carcinoma; (18)Fluorine fluorodeoxyglucose; Positron emission tomography; computed tomography; Metastatic disease
Ask authors/readers for more resources
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. (18)Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography-computed tomography (PET-CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET-CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available